Search research articles
Contact Us
Filters
Showing results (51-60 of 65) with videos related to
Page
of 7
Sort By:
Oncology Reports
|
September 14, 2017
Multimodal actions of the phytochemical sulforaphane suppress both AR and AR-V7 in 22Rv1 cells: Advocating a potent pharmaceutical combination against castration-resistant prostate cancer
Namrata Khurana, Hogyoung Kim, Partha K Chandra, et al.
Plos One
|
January 28, 2014
Nrf1 and Nrf2 transcription factors regulate androgen receptor transactivation in prostate cancer cells
Michelle A Schultz, Sharika S Hagan, Amrita Datta, et al.
Cancer Letters
|
March 23, 2015
Selective targeting of FAK-Pyk2 axis by alpha-naphthoflavone abrogates doxorubicin resistance in breast cancer cells
Amrita Datta, Nobel Bhasin, Hogyoung Kim, et al.
Experimental Biology and Medicine (Maywood, N.J.)
|
February 16, 2011
Prognostic significance of cytoplasmic SOX9 in invasive ductal carcinoma and metastatic breast cancer
Geetika Chakravarty, Krzysztof Moroz, Nick M Makridakis, et al.
Antioxidants (Basel, Switzerland)
|
February 25, 2022
Pre-Exposure to Stress-Inducing Agents Increase the Anticancer Efficacy of Focused Ultrasound against Aggressive Prostate Cancer Cells
Hakm Y Murad, Partha K Chandra, Charles A Kelly, et al.
Scientific Reports
|
October 4, 2018
Mesenchymal stem cells are attracted to latent HIV-1-infected cells and enable virus reactivation via a non-canonical PI3K-NFκB signaling pathway
Partha K Chandra, Samantha L Gerlach, Chengxiang Wu, et al.
Cancer Letters
|
August 29, 2017
Manumycin A suppresses exosome biogenesis and secretion via targeted inhibition of Ras/Raf/ERK1/2 signaling and hnRNP H1 in castration-resistant prostate cancer cells
Amrita Datta, Hogyoung Kim, Madhu Lal, et al.
Scientific Reports
|
May 27, 2018
High-throughput screening identified selective inhibitors of exosome biogenesis and secretion: A drug repurposing strategy for advanced cancer
Amrita Datta, Hogyoung Kim, Lauren McGee, et al.
Experimental Biology and Medicine (Maywood, N.J.)
|
January 30, 2009
Phosphorylated insulin like growth factor-I receptor expression and its clinico-pathological significance in histologic subtypes of human thyroid cancer
Geetika Chakravarty, Alfredo A Santillan, Chad Galer, et al.
Journal of Pineal Research
|
April 11, 2015
Doxorubicin resistance in breast cancer is driven by light at night-induced disruption of the circadian melatonin signal
Shulin Xiang, Robert T Dauchy, Adam Hauch, et al.
Page
of 7
Search research articles
Search
Showing results (51-60 of 65) with videos related to
Sort By:
Page
of 7
Oncology Reports
|
September 14, 2017
Multimodal actions of the phytochemical sulforaphane suppress both AR and AR-V7 in 22Rv1 cells: Advocating a potent pharmaceutical combination against castration-resistant prostate cancer
Namrata Khurana, Hogyoung Kim, Partha K Chandra, et al.
Plos One
|
January 28, 2014
Nrf1 and Nrf2 transcription factors regulate androgen receptor transactivation in prostate cancer cells
Michelle A Schultz, Sharika S Hagan, Amrita Datta, et al.
Cancer Letters
|
March 23, 2015
Selective targeting of FAK-Pyk2 axis by alpha-naphthoflavone abrogates doxorubicin resistance in breast cancer cells
Amrita Datta, Nobel Bhasin, Hogyoung Kim, et al.
Experimental Biology and Medicine (Maywood, N.J.)
|
February 16, 2011
Prognostic significance of cytoplasmic SOX9 in invasive ductal carcinoma and metastatic breast cancer
Geetika Chakravarty, Krzysztof Moroz, Nick M Makridakis, et al.
Antioxidants (Basel, Switzerland)
|
February 25, 2022
Pre-Exposure to Stress-Inducing Agents Increase the Anticancer Efficacy of Focused Ultrasound against Aggressive Prostate Cancer Cells
Hakm Y Murad, Partha K Chandra, Charles A Kelly, et al.
Scientific Reports
|
October 4, 2018
Mesenchymal stem cells are attracted to latent HIV-1-infected cells and enable virus reactivation via a non-canonical PI3K-NFκB signaling pathway
Partha K Chandra, Samantha L Gerlach, Chengxiang Wu, et al.
Cancer Letters
|
August 29, 2017
Manumycin A suppresses exosome biogenesis and secretion via targeted inhibition of Ras/Raf/ERK1/2 signaling and hnRNP H1 in castration-resistant prostate cancer cells
Amrita Datta, Hogyoung Kim, Madhu Lal, et al.
Scientific Reports
|
May 27, 2018
High-throughput screening identified selective inhibitors of exosome biogenesis and secretion: A drug repurposing strategy for advanced cancer
Amrita Datta, Hogyoung Kim, Lauren McGee, et al.
Experimental Biology and Medicine (Maywood, N.J.)
|
January 30, 2009
Phosphorylated insulin like growth factor-I receptor expression and its clinico-pathological significance in histologic subtypes of human thyroid cancer
Geetika Chakravarty, Alfredo A Santillan, Chad Galer, et al.
Journal of Pineal Research
|
April 11, 2015
Doxorubicin resistance in breast cancer is driven by light at night-induced disruption of the circadian melatonin signal
Shulin Xiang, Robert T Dauchy, Adam Hauch, et al.
Page
of 7